Monday, September 2, 2013

Quitting smoking reduces certain risks to levels of never-smokers

"It's never too late to quit smoking," say researchers behind a new study revealed this week. The team found that while quitting smoking may not reduce the damage done to arteries, it reduces the risk of heart attack and death to levels enjoyed by people who have never smoked.


James Min, an associate professor with New York Presbyterian Hospital and Weill Cornell Medical College in the US, and colleagues presented their findings at the European Society of Cardiology Congress 2013, which is taking place in Amsterdam this week.


Prof. Min says:


"Our results show that quitting smoking does not reduce the amount of disease smoking causes in the coronary arteries, but it does reduce the risk of heart attack and death to the levels of non-smokers."


He explains that we already know smoking is a risk factor for cardiovascular disease and that several studies have found quitting smoking can reduce people's risk for heart attack and death. But none has looked at the effect quitting smoking has on presence and severity of coronary artery disease.


Coronary artery disease (CAD) is the most common type of heart disease, which is the leading cause of death in the US. According to the Centers for Disease Control and Prevention (CDC), heart disease killed nearly 600,000 Americans in 2010.


CAD is a leading cause of heart attack and occurs when cholesterol deposits called plaque build up in the arteries that supply blood to the heart. The plaque build up causes the arteries to become narrow over time, a process known as atherosclerosis.


For some people, the first sign of CAD is a heart attack, which happens when plaque completely blocks an artery carrying blood to the heart or when a piece of plaque breaks off, blocking blood flow in a coronary artery.


Effects of quitting smoking


Prof. Min says they wanted to find out what effect quitting smoking might have on the risk of cardiovascular events, death and the severity of CAD.


For their investigation, they looked at data from the CONFIRM (Coronary CT Evaluation for Clinical Outcomes: An International Multicenter Study) registry.


CONFIRM has collected heart disease and associated risk data from over 13,300 patients in nine countries on three continents: Europe, North America and East Asia. The patients include over 2,800 current smokers, over 3,100 past smokers and over 7,300 never-smokers.


The heart disease data was collected using coronary computed tomographic angiography (CCTA), a non-invasive scan that enables direct visualization of the coronary arteries.


When they analyzed the data, the researchers found that:



  • Severely blocked arteries were more common in past and current smokers than never-smokers.

  • Current and past smokers had a 1.5-fold higher chance of severe narrowing (stenosis) in 1 and 2 major arteries of the heart, and a 2-fold higher chance of severe narrowing in all three major heart arteries.

  • After 2 years of follow-up, 2.1% of the patients had either had a heart attack or died.

  • Heart attacks and deaths were nearly 2-fold higher among current smokers than never-smokers.


The team also found that despite CAD being more common and more severe among past smokers, their rates of heart attacks and death were the same as those of never-smokers.


And these rates persisted even when matched against never-smokers of the same gender, similar age and risk factors for CAD.


Prof. Min says theirs is the first study to show that while the damage to arteries remains, the risk for heart attacks and death falls to that of non-smokers when smokers quit.


He says more work is planned to find out exactly why this should be the case, and there are still lots of unanswered questions:


"For example, will the severe blockages observed in patients who have quit smoking provoke adverse events after 2 years (the duration of the present study)?"


"Further, does the duration of smoking or the number of cigarettes smoked per day affect the severity of CAD or the prognosis related to quitting smoking?"


"It's never too late to quit smoking," he says, "This study clearly shows that stopping smoking lowers the risk of heart attacks and death to the level of never-smokers."


A study published earlier this year found that quitting smoking by the age of 40 restores life expectancy to near normal.


Written by Catharine Paddock PhD




Copyright: Medical News Today

Not to be reproduced without permission of Medical News Today




Highlights from the XV International Congress of Immunology, Milan

New perspectives against transplant rejection New scientific results that could one day allow transplanted patients to avoid side effects caused by immunosuppressive therapy were presented at the International Congress of Immunology in Milan. Researchers are testing regulatory cells that can be followed once infused in patients: by doing this, it will be possible to understand if these cells survive and reach their goal, which is convincing the immune system to ignore extraneous tissues coming from the donor...

New report examines use of preventive services and prevalence of health risk factors

AARP Public Policy Institute has released a new report examining the use of preventive services and the prevalence of risk factors among midlife adults. The report, "Use of Clinical Preventive Services and Prevalence of Health Risk Factors Among Adults Aged 50-64," breaks down national and state-level data by racial/ethnic, socioeconomic and health insurance coverage status and highlights disparities across these groups...

European approval for new renal denervation system that reduces total ablation time by more than 80 percent

St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, has announced the CE Mark approval of its next-generation EnligHTN™ Renal Denervation System for treating patients with drug-resistant, uncontrolled hypertension. The system features an advanced generator that delivers simultaneous ablations via a multi-electrode catheter, reducing total ablation time with the new EnligHTN system by more than 80 percent in comparison to the first generation system, from approximately 24 minutes to four minutes...

Drugs effective at preventing breast cancer metastasis in mouse model

When a cancer cell sloughs off the edge of a tumor in the breast, it faces a tough road to survive. The cell must not only remain physically intact as it rushes through blood vessels, but it also must find a new organ to lodge itself in, take in enough nutrients and oxygen to stay alive, and begin dividing, all while escaping notice by the body's immune system. A team of Howard Hughes Medical Institute (HHMI) scientists has discovered that some loose breast cancer cells, have a leg up on survival - the genes they express make them more likely to prosper in bone tissue...

Neurologists use algorithm for early diagnosis of Alzheimer's disease

Patients with Alzheimer's disease currently undergo neuropsychological testing to detect signs of the disease. The test results are difficult to interpret and are insufficient for making a definitive diagnosis. But as scientists have already discovered, activity in certain areas of the cerebral cortex is affected even in the early stages of the disease...

Breast cancer prognosis predicted by protein

Researchers have identified a protein that they believe may help predict breast cancer prognosis, potentially relieving thousands of women at low risk from having to undergo painful, oft-debilitating therapies, while insuring the most successful treatments for those at high risk. The research was published ahead of print in the journal Molecular and Cellular Biology. Using bioinformatics techniques, the authors showed that the levels of expression of some 1,200 genes that are directly controlled by the enzyme, EZH2, correlates with the aggressiveness of breast cancer cases...